Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics Revenue

Aclaris Therapeutics had revenue of $4.35M in the quarter ending September 30, 2024, a decrease of -53.18%. This brings the company's revenue in the last twelve months to $27.08M, up 26.35% year-over-year. In the year 2023, Aclaris Therapeutics had annual revenue of $31.25M with 5.03% growth.

• Revenue (ttm): $27.08M
• Revenue Growth: +26.35%
• P/S Ratio: 10.41
• Revenue / Employee: $297,571
• Employees: 91
• Market Cap: 274.65M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	31.25M	1.50M	5.03%
Dec 31, 2022	29.75M	22.99M	340.05%
Dec 31, 2021	6.76M	279.00K	4.30%
Dec 31, 2020	6.48M	2.26M	53.35%
Dec 31, 2019	4.23M	-1.92M	-31.28%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.